Effective treatment with abciximab for consecutive bilateral middle cerebral artery occlusion

Cerebrovasc Dis. 2006;21(5-6):419-21. doi: 10.1159/000092131. Epub 2006 Mar 20.

Authors

Volker Puetz¹, Matthias Weise, Ruediger von Kummer, Georg Gahn

Affiliation

¹ Department of Neurology, Technical University Dresden, Dresden, Germany. [email protected]

PMID: 16549911
DOI: 10.1159/000092131

No abstract available

Publication types

Case Reports

MeSH terms

Abciximab
Antibodies, Monoclonal / administration & dosage*
Drug Administration Schedule
Female
Fibrinolytic Agents / therapeutic use
Humans
Immunoglobulin Fab Fragments / administration & dosage*
Infarction, Middle Cerebral Artery / diagnostic imaging
Infarction, Middle Cerebral Artery / drug therapy*
Infusions, Intravenous
Middle Aged
Platelet Aggregation Inhibitors / administration & dosage*
Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors
Radiography
Recurrence
Tissue Plasminogen Activator / therapeutic use
Treatment Outcome
Ultrasonography

Substances

Antibodies, Monoclonal
Fibrinolytic Agents
Immunoglobulin Fab Fragments
Platelet Aggregation Inhibitors
Platelet Glycoprotein GPIIb-IIIa Complex
Tissue Plasminogen Activator
Abciximab